tiprankstipranks
Trending News
More News >
Taysha Gene Therapies price target raised to $8 from $6 at Needham
PremiumThe FlyTaysha Gene Therapies price target raised to $8 from $6 at Needham
4d ago
Positive Outlook for Taysha Gene Therapies: Buy Rating on Promising TSHA-102 Advancements
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Buy Rating on Promising TSHA-102 Advancements
5d ago
Positive Outlook for Taysha Gene Therapies: Strong Study Design and Promising Data Support Buy Rating
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Strong Study Design and Promising Data Support Buy Rating
8d ago
Taysha Gene Therapies Announces Pivotal Trial Design for TSHA-102
PremiumCompany AnnouncementsTaysha Gene Therapies Announces Pivotal Trial Design for TSHA-102
9d ago
Taysha Gene Therapies announces Part B trial design for TSHA-102
Premium
The Fly
Taysha Gene Therapies announces Part B trial design for TSHA-102
9d ago
Taysha Gene Therapies announces common stock offering, no amount given
Premium
The Fly
Taysha Gene Therapies announces common stock offering, no amount given
9d ago
Taysha Gene Therapies’ Positive Q1 2025 Earnings Call
PremiumCompany AnnouncementsTaysha Gene Therapies’ Positive Q1 2025 Earnings Call
22d ago
Positive Outlook for Taysha Gene Therapies: Expedited FDA Alignment and Strong Financial Position Support Buy Rating
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Expedited FDA Alignment and Strong Financial Position Support Buy Rating
22d ago
Taysha Gene Therapies reports Q1 EPS (8c) vs (10c) last year
Premium
The Fly
Taysha Gene Therapies reports Q1 EPS (8c) vs (10c) last year
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100